Skip to Main Content

An official website of the United States government

Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.

Name Principal Investigator Institution Study Date Approved Project ID
Different diets and the risk of lung cancer: a large prospective multicenter study Yingxian Dong West China hospital of Sichuan University PLCO May 29, 2024 PLCO-1566
Positive associations between dietary-induced acid load and renal cancer incidence and mortality: results from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Linglong Peng The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. PLCO May 29, 2024 PLCO-1570
Adherence to Lifelines Diet Score (LLDS) is associated with lower lung cancer risk in 98,459 participants: a large prospective study Haitao Gu The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. PLCO May 14, 2024 PLCO-1560
Leveraging Machine Learning for Gynecologic Cancer Diagnosis: Visual Question Answering Elham Dolatabadi York University PLCO May 14, 2024 PLCOI-1557
Interactions, mediating effects, and nonlinear effects of biological markers, genomics and environmental exposures on the occurrence and prognosis of various types of cancers Jiahui Lao Department of Clinical Epidemiology, Shengjing Hospital of China Medical University PLCO May 14, 2024 PLCO-1550
Validate Colon Cancer Model trained on synthetic data against PLCO dataset patient data Jeremy Howard Lucem Health, Inc. PLCO May 14, 2024 PLCO-1553
Biomarker-assisted Decision Rule for Risk Classification under a positive predictive value - constraint: Application to disease screening Yingqi Zhao Fred Hutchinson Cancer Center PLCO May 14, 2024 PLCO-1556
Risk and Influencing Factors for Subsequent Primary Lung Cancer After Treatment of Breast Cancer Yingxian Dong West China hospital of Sichuan University PLCO Apr 29, 2024 PLCO-1549
Diet and risks of lung cancer Kanran Wang Chongqing University Cancer Hospital PLCO Apr 29, 2024 PLCO-1547
AI Modeling Project for Predicting Treatment Response in Non-Small Cell Lung Cancer Anna Gracia Colmenarejo Universidad Internacional de La Rioja PLCO Apr 29, 2024 PLCO-1542
How effective is PSA Screening as a mode of prevention for Prostate Cancer in Men over the age of 50? Jiana Karthikeyan Franconian International School PLCO Apr 29, 2024 PLCO-1543
A novel accuracy metric for general M-class classification when subclasses are involved Nan Nan State University of New York at Buffalo PLCO Apr 29, 2024 PLCO-1531
Development and Validation of In-House Artificial Intelligence Models for Mutation and Survival Prediction Nikolaos Tsiknakis Karolinska Institutet PLCO Apr 29, 2024 PLCOI-1539
Prototype System for Supporting Urologists in Bladder Tumor Detection Jaime Hugo Puebla Lomas Instituto Politécnico Nacional PLCO Apr 18, 2024 PLCOI-1527
Is Supervised machine learning algorithm comparative over nomograms in predicting biochemical recurrence after prostatectomy: a validation study Kheng Sit Lim AiM Medical Pte Ltd PLCO Apr 18, 2024 PLCO-1533
Predicting cancer-specific mortality using histopathology slides Shu Jiang Washington University in St. Louis PLCO Apr 18, 2024 PLCOI-1532
AI/ML based risk analysis for early cancer detection and prevention for high-risk, understudied, and/or underserved cancer populations. Amalendu Ranjan UNT Health Science Center PLCO Apr 18, 2024 PLCO-1529
Precision nutrition approaches to prostate cancer prevention: role of insulinemic dietary patterns on lethality Fred Tabung The Ohio State University Comprehensive Cancer Center PLCO Apr 16, 2024 2023-0064
Using Explainability Methods to Unpack Disease Predictions for Individual-level Inference: An Empirical Study of the Lung Cancer Prediction Problem Gorkem Turgut Ozer University of New Hampshire PLCO Apr 12, 2024 PLCO-1530
Single-index mixture cure model with interval-censored data Xiaoru Huang Jinan University PLCO Apr 12, 2024 PLCO-1528